Current Role of Hormonal Treatment in Prostate Cancer

Authors

  • Bannakij Lojanapiwat Division of Urology, Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

Keywords:

Current Role, Hormonal Treatment, Prostate Cancer

Abstract

-

References

Huggins C, Hodges CV. Studies on prostate cancer: the effect of castration, of estrogen, and of androgen injection on serum phosphatase in metastasis carcinoma of prostate-1941. J Urol 2002; 168: 9-12.

EAU Guidelines 2008 edition P65.

Melton LJ. Declined in bilateral orchiectomy for prostate cancer in Olmsted county, Minesota. Mayo Clinic Proc 2001.

Trachtenberg J .Endocrine therapy: non-estrogen pharmacological manipulation. Siminar Urol 1983; 1: 288-90.

Jacobi et al. Treatment of advanced prostate cancer with parenteral cyprosterone acetate. Br J Urol 1980; 52: 208-15.

Barradell et al. Cyprosterone, A review of its pharmacology and therapeutic efficacy in prostate cancer. Drug Aging 1994; 5: 59-80.

Neri RO. Antiandrogen 1976; 2: 233-62.

Schellhammer PF,David JW.An evaluation of bicalutamide in the treatment of prostate cancer. Clin Prostate Cancer 2004; 2:213-9.

Weckerman D, Harzmann R. Hormone therapy in prostate cancer: LHRH agonist versus LHRH analogue. Eur Urol 2004; 46: 279-83.

Conde FA et al. Risk factors for male osteoporosis. Urol Oncol 21:380-3.

Cervenakov I, çHot flush çAn unpleasant symptom accompany antiandrogen therapy of patient of prostate. Int Uro Nephrol 2000; 32: 77-9.

Downloads

Published

2009-12-01

How to Cite

Lojanapiwat, B. (2009). Current Role of Hormonal Treatment in Prostate Cancer. Insight Urology, 30(2), 39–43. Retrieved from https://he02.tci-thaijo.org/index.php/TJU/article/view/252666

Issue

Section

Review article